Comments
Shares of Alkem Laboratories may come under pressure on Tuesday on USFDA observations. In a notification to the stock exchanges, the company said USFDA had conducted an inspection at the company's manufacturing facility at Baddi between March 2 and 10. It has received the inspection report which contains three 483 observations. "The company shall put together a detailed response with adequate corrective and preventive measures to address the US FDA," it said.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.